Arbutus Biopharma
Rajeev Singh, Ph.D. has a vast experience in the pharmaceutical industry, with a focus on analytical research and development. RAJEEV has held various leadership roles in companies such as Arbutus Biopharma Corporation, Douglas Pharmaceuticals, Akorn, Inc, Allan Pharmaceuticals, and Cipla Limited. Their expertise includes managing teams, developing analytical methods for drug products, responding to FDA letters for ANDA approvals, and overseeing the entire process from development to filing. Rajeev obtained their Doctor of Philosophy degree in Analytical Chemistry from the University of Mumbai.
Arbutus Biopharma
2 followers
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).